Gene Expression Profiling of Apoptosis-Related Genes in Human Atherosclerosis: Upregulation of Death-Associated Protein Kinase
暂无分享,去创建一个
D. Schrijvers | G. D. De Meyer | W. Martinet | A. Herman | M. Knaapen | M. Kockx | Wim Martinet | Dorien M Schrijvers | Guido R Y De Meyer | Jeff Thielemans | Michiel W M Knaapen | Arnold G Herman | Mark M Kockx | J. Thielemans
[1] A. Tedgui,et al. Current perspective on the role of apoptosis in atherothrombotic disease. , 2001, Circulation research.
[2] M. Bennett,et al. Human Blood-Derived Macrophages Induce Apoptosis in Human Plaque-Derived Vascular Smooth Muscle Cells by Fas-Ligand/Fas Interactions , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[3] A. Tedgui,et al. Apoptosis in the vasculature: mechanisms and functional importance , 2000, British journal of pharmacology.
[4] Mast Cell Chymase Induces Apoptosis of Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[5] W. Martinet,et al. Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation , 2001, Current opinion in lipidology.
[6] A. Kimchi,et al. Death-associated Protein (DAP) Kinase Plays a Central Role in Ceramide-induced Apoptosis in Cultured Hippocampal Neurons* , 2002, The Journal of Biological Chemistry.
[7] S. Polak‐Charcon,et al. DAP kinase links the control of apoptosis to metastasis , 1997, Nature.
[8] M. Cybulsky,et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.
[9] A. Herman,et al. Apoptosis in atherosclerosis: beneficial or detrimental? , 2000, Cardiovascular research.
[10] Richard T. Lee,et al. Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis: Using Genomic Technology to Identify a Potential Novel Pathway of Vascular Inflammation , 2000, Circulation.
[11] A. Kimchi,et al. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death , 2002, The Journal of cell biology.
[12] G. D. De Meyer,et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. , 1998, Circulation research.
[13] W. Erl,et al. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells , 1999 .
[14] A. Kimchi,et al. DAP‐kinase is a Ca2+/calmodulin‐dependent, cytoskeletal‐associated protein kinase, with cell death‐inducing functions that depend on its catalytic activity , 1997, The EMBO journal.
[15] A. Kimchi,et al. Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain , 1999, The Journal of cell biology.
[16] K. Williams,et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. , 1996, The Journal of clinical investigation.
[17] A. Kimchi,et al. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions , 1998, Oncogene.
[18] G. D. De Meyer,et al. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.
[19] M. Eisenstein,et al. A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Zeiher,et al. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[21] A. Kimchi,et al. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.
[22] G. Evan,et al. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.
[23] Hiroshi Takahashi,et al. Developmental changes in distribution of death‐associated protein kinase mRNAs , 1999, Journal of neuroscience research.
[24] M. Bennett,et al. Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. , 2000, Circulation research.
[25] W. Jacob,et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.
[26] S. Ylä-Herttuala,et al. Functional genomics and DNA array techniques in atherosclerosis research. , 1999, Current Opinion in Lipidology.
[27] S. Schwartz,et al. Monoclonality of smooth muscle cells in human atherosclerosis. , 1997, The American journal of pathology.
[28] Gustavo Droguett,et al. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation , 2000, Nature Cell Biology.
[29] G. D. De Meyer,et al. Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering , 2001, Circulation research.